← back to search

Yunhui Hu

Tianjin University of Traditional Chinese Medicine · CN
Area of research
Complementary and alternative medicine · Oncology
Research interest
Research focused on Cancer research and Endoplasmic reticulum, with related work in Neuroinflammation, Unfolded protein response, Triple-negative breast cancer. Notable publications include 'microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7', 'MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions', and 'Modulating endoplasmic reticulum stress in APP/PS1 mice by Gomisin B and Osthole in Bushen-Yizhi formula: Synergistic effects and therapeutic implications for Alzheimer's disease'.
h-index
citations
48
works
7
NIH funding
primary concept
email

Recent publications

Yangxue Qingnao Wan ameliorates cognitive impairment in scopolamine-induced AD mice via modulating neuropeptide signaling pathways and suppressing neuroinflammation
Phytomedicine 2025cited by 1position: middledoi
Yangxue Qingnao Wan Ameliorates Cognitive Impairment in Scopolamine-Induced Ad Mice Via Modulating Neuropeptide Signaling Pathways and Suppressing Neuroinflammation
SSRN Electronic Journal 2025cited by 0position: middledoi
Integrative multi-omics approach for drug repositioning in Alzheimer's disease
Precision medication. 2025cited by 0position: lastdoi
An endophenotype network strategy uncovers YangXue QingNao Wan suppresses Aβ deposition, improves mitochondrial dysfunction and glucose metabolism
Phytomedicine 2024cited by 8position: middledoi
Modulating endoplasmic reticulum stress in APP/PS1 mice by Gomisin B and Osthole in Bushen-Yizhi formula: Synergistic effects and therapeutic implications for Alzheimer's disease
Phytomedicine 2023cited by 25position: middledoi
Network-based identification and mechanism exploration of active ingredients against Alzheimer’s disease via targeting endoplasmic reticulum stress from traditional chinese medicine
Computational and Structural Biotechnology Journal 2023cited by 14position: middledoi
Ruanjian Sanjie Decoction Induces Apoptosis in Triple-negative Breast Cancer Cells by Downregulating cIAP1/2 and XIAP
2020cited by 0position: middledoi
MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
Journal of Cancer 2017cited by 38position: middledoi
microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7
DNA and Cell Biology 2016cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jiansong Fang · Guangzhou University of Chinese Medicine6 papers (2023–2025)Wenjia Wang · Shandong University4 papers (2023–2025)Shuhuan Fang · Guangzhou University of Chinese Medicine4 papers (2023–2025)Xiaolian Zhang · Guangzhou University of Chinese Medicine4 papers (2024–2025)Jinna Yang · Nanjing University of Chinese Medicine4 papers (2024–2025)Chuipu Cai · Guangzhou University of Chinese Medicine4 papers (2023–2025)Kaimin Guo · Tianjin University of Traditional Chinese Medicine3 papers (2025–2025)Jieqi Zhang · Guangzhou University of Chinese Medicine3 papers (2024–2025)Sheng Zhang · Cornell University2 papers (2016–2017)Jingjing Liu · Zhejiang Chinese Medical University2 papers (2016–2017)Wentao Wei · Guangzhou University of Chinese Medicine2 papers (2025–2025)Zhendong Shi · Ministry of Education of the People's Republic of China2 papers (2016–2017)Pengcheng Yang · Zhejiang University2 papers (2025–2025)Xiaxia Ren · Tianjin University of Traditional Chinese Medicine2 papers (2025–2025)Xiao Meng · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2025–2025)Qi Wang · Hebei Medical University1 papers (2023–2023)Peng Liu · Shenyang Pharmaceutical University1 papers (2024–2024)Lei Liu · Chinese General Hospital College of Nursing and Liberal Arts1 papers (2020–2020)Luyao Wang · Ruijin Hospital1 papers (2020–2020)Jin Zhang · Fudan University1 papers (2017–2017)